- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Mesothelin (MSLN) is a glycosylphosphatidylinositol-anchored cell surface protein with low baseline expression in normal mesothelial cells but marked upregulation in malignancies including mesothelioma, ovarian carcinoma, and pancreatic adenocarcinoma. MSLN Antibody for WB is used to detect mesothelin protein expression in denatured lysates and to evaluate its processing state, abundance, and regulation in cancer cell models. The protein undergoes characteristic proteolytic cleavage, generating distinct molecular species that are routinely observed in western blot analysis.
Mesothelin antibody, also referred to as MSLN antibody or mesothelioma-associated antigen antibody, recognizes mesothelin under denaturing conditions and enables detection of both precursor and processed forms. The full-length precursor is approximately 70 kDa, while proteolytic processing yields a membrane-associated fragment typically observed at approximately 40-50 kDa. In many cancer cell lines, the processed form is the predominant species detected, making this lower molecular weight band the primary indicator of mesothelin expression in western blot experiments.
As a western blot antibody, this clone provides robust detection of endogenous mesothelin in tumor-derived cell lysates such as OVCAR-3. A strong band in the 40-50 kDa range is consistent with mature, processed mesothelin, while less intense higher molecular weight bands may represent precursor protein or incompletely processed intermediates. Apparent molecular weight may vary depending on glycosylation status and sample preparation conditions, and slight band shifts should be interpreted within the context of mesothelinâs known post-translational processing.
Detection of mesothelin by western blot provides important insight into tumor-associated protein expression and complements tissue-based analyses. Elevated mesothelin levels are associated with tumor progression, cell adhesion, and metastatic dissemination through interaction with MUC16 (CA125). Monitoring mesothelin expression and processing by western blot is therefore widely used in cancer research to assess tumor biology and protein regulation across experimental systems.
Overall, MSLN Antibody for WB enables reliable and specific detection of mesothelin protein, with clear identification of both precursor and processed forms, supporting accurate interpretation of banding patterns and detailed analysis of mesothelin expression in cancer cell lysates.
This Mesothelin antibody is part of a broader Mesothelin antibody panel offered by NSJ Bioreagents.
Optimal dilution of the MSLN Antibody for WB / Mesothelin Western Blot Antibody should be determined by the researcher.
A recombinant partial protein sequence (within amino acids 273-407) from the human protein was used as the immunogen for the recombinant MSLN antibody.
Aliquot the recombinant MSLN antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Mesothelin antibody, MSLN antibody, Mesothelioma antigen antibody, Tumor marker antibody, CA125-binding protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.